News | August 22, 2013

American Society of Nuclear Cardiology Launches New Online Education Activity on Reducing Radiation Exposure

August 22, 2013 — The American Society of Nuclear Cardiology (ASNC) has recently released an online education program for physicians and technologists involved in the practice of nuclear cardiology. This program offers continuing education credits and provides valuable quality control procedures and radiation safety information.

“Patient-Centered Imaging: Strategies for Reducing Radiation Dose Levels in Nuclear Cardiology Studies” is an interactive case-based online CME/CE activity designed to increase learners’ competence on the appropriateness of cardiac imaging testing and the rationale for reducing exposure to ionizing radiation in adults who are at risk for coronary artery disease. The activity is a valuable guide for healthcare professionals, including hospital practice administrators, who are involved in the field of nuclear cardiology.

The objectives of the program are for participants, upon completion of this online educational activity, to be able to:

  • Demonstrate the importance of using appropriate use criteria to select the nuclear imaging tests and radiopharmaceuticals that will result in the lowest possible dose of radiation;
  • Review factors that influence use of radiation exposure (age, medical condition, etc.); and
  • Demonstrate techniques, technologies, software applications and acquisition parameters that will reduce radiation exposure.


The program faculty includes ASNC’s current president, James A. Arrighi, M.D., FASNC (Rhode Island Hospital/Alpert Medical School of Brown University), and vice president, Brian G. Abbott, M.D., FASNC (Rhode Island Cardiology Center/Alpert Medical School of Brown University). Additional faculty includes Gordon DePuey, M.D., FASNC; April Mann, CNMT, RT(N), NCT, FASNC; Leslee J. Shaw, Ph.D., FASNC; Kim A. Williams, Sr., M.D., FASNC; and Jack A. Ziffer, M.D., Ph.D., FASNC.

For more information: http://www.asnc.org/content_15364.cfm

Related Content

Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter
Technology | Nuclear Imaging | October 19, 2017
Biodex Medical Systems announced the full release of the Atomlab Dose Calibrator and Wipe Test Counter to the market...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound | October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
ScImage and Invia Partnership Announced
News | PACS | September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging | September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
Overlay Init